September 12, 2021. Hydroxychloroquine for Post Exposure Prophylaxis May Reduce COVID-19 Infection in Young People and if it is Initiated Early
This following article(not peer reviewed yet, in pre-print) is a , placebo-controlled, study which gave hydroxychloroquine (HCQ) or placebo to people who were exposed to COVID-19. In addition, it divided
September 11, 2021. Hydroxychloroquine for Pre Exposure Prophylaxis is Safe But Did Not Show Statistically Significant Effectiveness Preventing COVID-19
This following article(not peer reviewed yet, in pre-print) is a multicenter, randomized, placebo-controlled, double-blind, parallel-group trial. It provided a loading dose of hydroxychloroquine (HCQ)
$ 1.555
30